Rhotekin-1 is a novel interacting protein and regulator of TRPC6 activity.

Saved in:
Bibliographic Details
Title: Rhotekin-1 is a novel interacting protein and regulator of TRPC6 activity.
Authors: Lavanderos B; Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.; Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Santiago, Chile., Orellana-Serradell O; Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.; Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Santiago, Chile., Maureira D; Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.; Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Santiago, Chile., Cruz P; Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.; Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Santiago, Chile., Silva I; Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.; Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Santiago, Chile.; Centro de Oncología de Precisión, Universidad Mayor, Santiago, Chile., Toledo J; Red de Equipamiento Científico Avanzado (REDECA), Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile., González-Avendaño M; Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Santiago, Chile.; Center for Bioinformatics and Molecular Simulation, Faculty of Engineering, Universidad de Talca, Chile., López J; Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.; Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Santiago, Chile., Santos R; Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.; Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Santiago, Chile., Arancibia F; Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Santiago, Chile.; Program of Physiology and Biophysics, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile., Varela D; Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Santiago, Chile.; Program of Physiology and Biophysics, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile., Cáceres M; Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.; Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Santiago, Chile.; Millennium Institute of Immunology and Immunotherapy (IMII), Santiago, Chile., Vergara-Jaque A; Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Santiago, Chile.; Center for Bioinformatics and Molecular Simulation, Faculty of Engineering, Universidad de Talca, Chile., Cerda O; Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.; Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Santiago, Chile.
Source: The FEBS journal [FEBS J] 2025 Aug; Vol. 292 (16), pp. 4353-4374. Date of Electronic Publication: 2025 Mar 02.
Publication Type: Journal Article
Journal Info: Publisher: Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies Country of Publication: England NLM ID: 101229646 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-4658 (Electronic) Linking ISSN: 1742464X NLM ISO Abbreviation: FEBS J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1742-4658
DOI:10.1111/febs.70028